Magnesium Deficiency Induces Bone Loss in the Rat

Disorders in which magnesium (Mg) depletion is common have an associated high incidence of osteoporosis. Mg depletion in humans results in hypocalcemia, low serum parathyroid hormone (PTH) and 1,25(OH) 2 -vitamin D levels, as well as PTH and vitamin D resistance which may serve as mechanisms for the development of osteoporosis. In order to determine if isolated Mg depletion will result in bone loss, we have induced dietary Mg deficiency in the rat. Adult (290 g) female rats were given either a low-Mg diet (2 mg/100 g chow; n = 6) or a normal control Mg diet (63 mg/100 g chow; n = 6). Dietary calcium (Ca) was normal in both groups (592 mg/100 g chow). At 12 weeks, blood was obtained for serum Mg, Ca, PTH, 1,25(OH) 2 -vitamin D, and osteocalcin determinations. The rats were then euthanized and the femurs obtained for mineral analysis and histomorphometry. Serum Mg in the low-Mg group was less than control (0.4 ± 0.2 vs. 1.9 ± 0.2 mg/dl, p < 0.001; mean ± SD) while serum Ca was higher (11.7 ± 0.5 vs. 9.3 ± 0.4 mg/dl, p < 0.001). PTH was suppressed in the Mg-deficient group (36 ± 16 vs. 109 ± 30 pg/ml in controls, p < 0.002). Serum 1,25(OH) 2 -vitamin D was also suppressed in the Mg-deficient animals (7.1 ± 4.8 vs. 28.5 ± 8.2 pg/ml in controls, p < 0.002). Serum osteocalcin levels were not different (19.8 ± 2.5 ng/ml in Mg-deficient rats vs. 15.3 ± 3.4 ng/ml in controls). While the ash weight of Ca and phosphorus in the femur did not change, the ash weight of Mg fell (low-Mg group 0.55 ± 0.01%, controls 0.65 ± 0.02%, p < 0.001). Histomorphometry demonstrated reduction in bone mass; the trabecular bone volume in the femur of the low-Mg group was reduced from control (7.7 ± 0.2 vs. 13.7 ± 1.9%, p < 0.002). A surprising new observation was an increase in osteoclast (OC) bone resorption with Mg depletion. The number of OC per millimeter bone surface was 16.9 ± 1.3 in the low-Mg group versus 7.8 ± 1.5 in controls (p < 0.001). The percentage of bone surface occupied by OC was 38.3 ± 3.7 in the low-Mg group versus 17.7 ± 2.4 in controls (p < 0.001). This increased resorption occurred with an inappropriate non-altered bone-forming surface relative to control (% osteoid surface: low-Mg group 2.4 ± 0.7 vs. controls 2.6 ± 0.4; % osteoid volume: low-Mg group 0.25 ± 0.09 vs. controls 0.38 ± 0.06; number of osteoblasts per millimeter bone surface: low-Mg group 0.9 ± 0.3 vs. controls 1.3 ± 0.3). No increase in bone-forming surface or osteoblast number despite an increase in